Immunization News and Research

RSS

New vaccine candidate shows great promise at fighting respiratory syncytial virus

Johns Hopkins Bloomberg School of Public Health researchers say a new candidate vaccine against respiratory syncytial virus (RSV) made with a weakened version of the virus shows great promise at fighting the disease, the leading cause of hospitalization for children under the age of one in the U.S.

5 Nov 2015

Deaths from avoidable risk factors: an interview with Dr Ali Mokdad, IHME

The study showed that about thirty percent to maybe half of the leading causes of death in the world are preventable. These are risk factors that you could manage and thus you could prevent a lot of premature deaths.

3 Nov 2015

Sinovac Dalian receives approval to start human clinical trials of varicella vaccine candidate

Sinovac Biotech Ltd., a leading provider of biopharmaceutical products in China, today announced that one of its subsidiaries, Sinovac Dalian, has received approval to begin human clinical trials on its varicella vaccine candidate. The clinical trial application for the varicella vaccine was officially accepted by the China Food and Drug Administration in January 2013.

26 Oct 2015

SAGE recommends pilot implementation of malaria vaccine to protect young children

The World Health Organization’s Strategic Advisory Group of Experts on Immunization (SAGE) recommended pilot projects to understand how to best use a vaccine that protects against malaria in young children.

26 Oct 2015

Takeda highlights safety, efficacy of vedolizumab for UC and CD at ACG Annual Scientific Meeting

Takeda Pharmaceuticals, U.S.A., Inc., today announced that data highlighting the efficacy and safety of vedolizumab for the treatment of adults with moderately to severely active ulcerative colitis (UC) and Crohn's disease (CD), will be presented during the 2015 American College of Gastroenterology Annual Scientific Meeting in Honolulu, Hawaii, held on October 16-21.

20 Oct 2015

Outreach program increases completion of HPV vaccination series by teens in safety-net settings

A joint study by UT Southwestern Medical Center and Parkland Health & Hospital System investigators found that a multicomponent outreach program increased completion of the three-dose human papillomavirus (HPV) vaccination series that reduces the risk of cervical cancer caused by the virus.

19 Oct 2015

U.S. News and World Report names MU Health Care as a 'Most Connected Hospital'

University of Missouri Health Care has been named a "Most Connected Hospital" by U.S. News and World Report for using health information innovations to improve patient care. MU Health Care is one of two health systems in Missouri to make the 2015-2016 list released today, Friday, Oct. 16.

19 Oct 2015

High dose flu vaccines significantly reduce hospitalization risk during influenza season

In the largest nursing home study to date on the effect of high dose flu vaccine, researchers found that shots with four times the strength of standard flu shots significantly reduced the risk of being hospitalized during the influenza season. There was a 1.2 percent difference (19.7 percent versus 20.9 percent) in admission for the group that received the high dose vaccine compared to the one that received the standard dose vaccine.

12 Oct 2015

Influenza-related pneumonia hospitalizations could be prevented through influenza vaccination

More than half of hospitalizations due to influenza pneumonia could be prevented by influenza vaccination, according to a study led by investigators at Vanderbilt University Medical Center, published this week in the Journal of the American Medical Association.

7 Oct 2015

MU Health Care wins global HIMSS Enterprise Nicholas E. Davies Award of Excellence

University of Missouri Health Care has received the global HIMSS Enterprise Nicholas E. Davies Award of Excellence for health care technology innovations that are improving patient outcomes.

6 Oct 2015

Patients with influenza-associated pneumonia less likely to receive influenza vaccine: Study

Among children and adults hospitalized with community-acquired pneumonia, those with influenza-associated pneumonia, compared with those with pneumonia not associated with influenza, had lower odds of having received an influenza vaccination, according to a study published online by JAMA.

6 Oct 2015

Polio no more in Nigeria, WHO says

The World Health Organization announced today that polio is no longer endemic in Nigeria. This is the first time that Nigeria has interrupted transmission of wild poliovirus, bringing the country and the African region closer than ever to being certified polio-free.

29 Sep 2015

Polio no more in Nigeria, WHO says

WHO announced today that polio is no longer endemic in Nigeria. This is the first time that Nigeria has interrupted transmission of wild poliovirus, bringing the country and the African region closer than ever to being certified polio-free.

26 Sep 2015

Optum and AMGF launch pilot collaborative to enhance adult vaccination rates

The American Medical Group Foundation (AMGF) and Optum, with support from Pfizer, are launching a pilot collaborative to improve adult vaccination rates.

23 Sep 2015

WHO and the Government of Saudi Arabia work together to care for health issues of hajj pilgrims

As an estimated 2 million Muslims from 184 countries gather in Saudi Arabia’s holy city of Mecca to take part in the annual hajj pilgrimage, months of preparations to care for health issues of pilgrims are also coming together.

22 Sep 2015

ACP awarded $1,002,884 Cooperative Agreement to increase adult immunization rates in US

The American College of Physicians (ACP) was awarded a $1,002,884 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) to increase immunization rates in the United States.

16 Sep 2015

CureVac announces official launch of U.S. operations in Cambridge, MA

CureVac, a clinical-stage biopharmaceutical company pioneering the field of mRNA-based technology, today announced the official launch of its U.S. operations in Cambridge, MA, as the company advances the development of its proprietary mRNA platform technology and multiple, clinical-stage mRNA therapeutics and vaccines.

10 Sep 2015

Researchers one step closer to developing synthetic and cheaper antivenoms

Researchers involved in an international collaboration across six institutions, including the University of Copenhagen and the National Aquarium of Denmark (Den Blå Planet), have successfully identified the exact composition of sea snake venom, which makes the future development of synthetic antivenoms more realistic.

4 Sep 2015

Global 'Call to Action Summit 2015' adopts DELHI DECLARATION to end preventable maternal and child deaths

The two-day global 'Call to Action Summit 2015' concluded today with Health Ministers and heads of country delegations from 22 countries adopting the DELHI DECLARATION on 'ending preventable maternal and child deaths'. The declaration was developed as an outcome of the high-level ministerial conclave held yesterday during the summit.

29 Aug 2015

Passport Health participates in clinical study to test effects of oral typhoid vaccination

Passport Health, in partnership with vaccine manufacturer PaxVax, Inc. is participating in a clinical study to test the effects of the oral typhoid vaccination, Vivotif (Typhoid Vaccine Live Oral Ty21a). The study will look at the side effects that could occur when taking Vivotif across the range of approved potencies.

28 Aug 2015

Immunization News and Research

New vaccine candidate shows great promise at fighting respiratory syncytial virus

Deaths from avoidable risk factors: an interview with Dr Ali Mokdad, IHME

Sinovac Dalian receives approval to start human clinical trials of varicella vaccine candidate

SAGE recommends pilot implementation of malaria vaccine to protect young children

Takeda highlights safety, efficacy of vedolizumab for UC and CD at ACG Annual Scientific Meeting

Outreach program increases completion of HPV vaccination series by teens in safety-net settings

U.S. News and World Report names MU Health Care as a 'Most Connected Hospital'

High dose flu vaccines significantly reduce hospitalization risk during influenza season

Influenza-related pneumonia hospitalizations could be prevented through influenza vaccination

MU Health Care wins global HIMSS Enterprise Nicholas E. Davies Award of Excellence

Patients with influenza-associated pneumonia less likely to receive influenza vaccine: Study

Polio no more in Nigeria, WHO says

Polio no more in Nigeria, WHO says

Optum and AMGF launch pilot collaborative to enhance adult vaccination rates

WHO and the Government of Saudi Arabia work together to care for health issues of hajj pilgrims

ACP awarded $1,002,884 Cooperative Agreement to increase adult immunization rates in US

CureVac announces official launch of U.S. operations in Cambridge, MA

Researchers one step closer to developing synthetic and cheaper antivenoms

Global 'Call to Action Summit 2015' adopts DELHI DECLARATION to end preventable maternal and child deaths

Passport Health participates in clinical study to test effects of oral typhoid vaccination

Industry Focus eBook - Cell biology (5th edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News